• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名库欣病男性患者11β-羟类固醇脱氢酶1(11β-HSD1)活性受损,导致未出现典型的库欣综合征表型。

Impaired 11β-HSD1 Activity in a Male Patient With Cushing Disease Resulting in Lack of the Full Cushingoid Phenotype.

作者信息

Weber Robert J, Kawaja Christopher, Wallerstein Robert, Kunwar Sandeep M, Liu Chienying

机构信息

Department of Medicine, Division of Endocrinology, University of California, San Francisco, CA 94143, USA.

Independent Researcher, USA.

出版信息

JCEM Case Rep. 2024 Sep 5;2(9):luae158. doi: 10.1210/jcemcr/luae158. eCollection 2024 Sep.

DOI:10.1210/jcemcr/luae158
PMID:39238944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11375565/
Abstract

We present a patient who had surgically confirmed CD but without the full cushingoid phenotype despite markedly elevated cortisol. Nonpathologic causes of elevated ACTH and cortisol were eliminated as were pathogenic variants in the glucocorticoid receptor gene. Further studies of urine metabolites, cortisol half-life, and the ratios of cortisone to cortisol conversion revealed impaired 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity. There have only been 2 prior reports of impaired 11β-HSD1 resulting in lack of classic cushingoid features in the past 2 decades. Our patient's presentation and previous reports demonstrate the key role of 11β-HSD1 in modulating intracellular cortisol concentration, therefore shielding the peripheral tissues from the effects of excess cortisol. When patients present with markedly elevated cortisol but without classic cushingoid features, impaired 11β-HSD1 should be considered in the differential diagnosis.

摘要

我们报告了一名患者,其经手术确诊为库欣病(CD),尽管皮质醇水平显著升高,但并无典型的库欣综合征表现。促肾上腺皮质激素(ACTH)和皮质醇升高的非病理性原因以及糖皮质激素受体基因的致病变异均被排除。对尿液代谢产物、皮质醇半衰期以及可的松与皮质醇转化比率的进一步研究显示,11β-羟类固醇脱氢酶1型(11β-HSD1)活性受损。在过去20年中,仅有2例先前报道称11β-HSD1活性受损导致缺乏典型的库欣综合征特征。我们患者的表现及先前的报道表明,11β-HSD1在调节细胞内皮质醇浓度方面起着关键作用,从而使外周组织免受过量皮质醇的影响。当患者出现皮质醇水平显著升高但无典型库欣综合征特征时,在鉴别诊断中应考虑11β-HSD1受损的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1791/11375565/16dd505b70f2/luae158f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1791/11375565/55dd2bee4972/luae158f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1791/11375565/53b29d4f012b/luae158f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1791/11375565/16dd505b70f2/luae158f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1791/11375565/55dd2bee4972/luae158f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1791/11375565/53b29d4f012b/luae158f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1791/11375565/16dd505b70f2/luae158f3.jpg

相似文献

1
Impaired 11β-HSD1 Activity in a Male Patient With Cushing Disease Resulting in Lack of the Full Cushingoid Phenotype.一名库欣病男性患者11β-羟类固醇脱氢酶1(11β-HSD1)活性受损,导致未出现典型的库欣综合征表型。
JCEM Case Rep. 2024 Sep 5;2(9):luae158. doi: 10.1210/jcemcr/luae158. eCollection 2024 Sep.
2
Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion.因可的松向皮质醇转化缺陷导致的库欣病患者无库欣样表型。
J Clin Endocrinol Metab. 2002 Jan;87(1):57-62. doi: 10.1210/jcem.87.1.8189.
3
Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.代谢综合征是一种细胞内库欣状态吗?多种体液因子对肝脏糖皮质激素激活酶(11β-羟类固醇脱氢酶1型)基因转录活性的影响。
Mol Cell Endocrinol. 2008 Mar 26;285(1-2):10-8. doi: 10.1016/j.mce.2008.01.012. Epub 2008 Feb 2.
4
Lack of regulation of 11beta-hydroxysteroid dehydrogenase type 1 during short-term manipulation of GH in patients with hypopituitarism.垂体功能减退患者短期生长激素治疗期间11β-羟类固醇脱氢酶1型调节缺失
Eur J Endocrinol. 2009 Sep;161(3):375-80. doi: 10.1530/EJE-09-0315. Epub 2009 Jun 23.
5
Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.生长激素、胰岛素样生长因子-I与皮质醇-可的松穿梭作用
Horm Res. 2001;56 Suppl 1:1-6. doi: 10.1159/000048126.
6
Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.11β-羟类固醇脱氢酶 1 和 2 在慢性鼻-鼻窦炎患者中的表达及其对鼻窦黏膜局部糖皮质激素激活的可能贡献。
J Allergy Clin Immunol. 2014 Oct;134(4):926-934.e6. doi: 10.1016/j.jaci.2014.03.033. Epub 2014 May 5.
7
11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess.11β-羟化酶 1 是调节循环糖皮质激素过多的组织特异性效应的主要调节因子。
Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):E2482-91. doi: 10.1073/pnas.1323681111. Epub 2014 Jun 2.
8
Regulation of 11β-HSD1 by GH/IGF-1 in key metabolic tissues may contribute to metabolic disease in GH deficient patients.生长激素/胰岛素样生长因子-1 对关键代谢组织中 11β-HSD1 的调节可能导致生长激素缺乏症患者发生代谢疾病。
Growth Horm IGF Res. 2022 Feb;62:101440. doi: 10.1016/j.ghir.2021.101440. Epub 2021 Nov 17.
9
In vivo evaluation of 11beta-hydroxysteroid dehydrogenase activity in the rabbit eye.兔眼中11β-羟基类固醇脱氢酶活性的体内评估。
J Ocul Pharmacol Ther. 2009 Jun;25(3):215-22. doi: 10.1089/jop.2008.0120.
10
Quantification of 11β-hydroxysteroid dehydrogenase 1 kinetics and pharmacodynamic effects of inhibitors in brain using mass spectrometry imaging and stable-isotope tracers in mice.使用质谱成像和稳定同位素示踪剂在小鼠大脑中定量 11β-羟甾类脱氢酶 1 动力学和抑制剂的药效学作用。
Biochem Pharmacol. 2018 Feb;148:88-99. doi: 10.1016/j.bcp.2017.12.013. Epub 2017 Dec 15.

本文引用的文献

1
Genome Sequencing for Diagnosing Rare Diseases.基因组测序在罕见病诊断中的应用。
N Engl J Med. 2024 Jun 6;390(21):1985-1997. doi: 10.1056/NEJMoa2314761.
2
11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial.11β-羟类固醇脱氢酶 1 抑制剂可减轻男性患者接受泼尼松龙治疗的不良反应:一项概念验证性随机双盲安慰剂对照试验
Nat Commun. 2023 Feb 23;14(1):1025. doi: 10.1038/s41467-023-36541-w.
3
11β-HSD as a New Target in Pharmacotherapy of Metabolic Diseases.11β-羟化酶作为代谢性疾病药物治疗的新靶点。
Int J Mol Sci. 2022 Aug 11;23(16):8984. doi: 10.3390/ijms23168984.
4
Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis.全外显子组和全基因组测序在孟德尔疾病中的应用:一项诊断和健康经济学分析。
Eur J Hum Genet. 2022 Oct;30(10):1121-1131. doi: 10.1038/s41431-022-01162-2. Epub 2022 Aug 15.
5
Association of chronic central serous chorioretinopathy with subclinical Cushing's syndrome.慢性中心性浆液性脉络膜视网膜病变与亚临床库欣综合征的关联。
Am J Ophthalmol Case Rep. 2022 Mar 4;26:101455. doi: 10.1016/j.ajoc.2022.101455. eCollection 2022 Jun.
6
Regulation of 11β-HSD1 by GH/IGF-1 in key metabolic tissues may contribute to metabolic disease in GH deficient patients.生长激素/胰岛素样生长因子-1 对关键代谢组织中 11β-HSD1 的调节可能导致生长激素缺乏症患者发生代谢疾病。
Growth Horm IGF Res. 2022 Feb;62:101440. doi: 10.1016/j.ghir.2021.101440. Epub 2021 Nov 17.
7
An Open-label Phase I/IIa Clinical Trial of 11β-HSD1 Inhibitor for Cushing's Syndrome and Autonomous Cortisol Secretion.11β-羟类固醇脱氢酶 1 抑制剂治疗库欣综合征和自主皮质醇分泌的开放标签 I/IIa 期临床试验。
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3865-e3880. doi: 10.1210/clinem/dgab450.
8
GENETICS IN ENDOCRINOLOGY: Glucocorticoid resistance syndrome.内分泌遗传学:糖皮质激素抵抗综合征。
Eur J Endocrinol. 2020 Feb 1;182(2):R15-R27. doi: 10.1530/EJE-19-0811.
9
Risk factors for incident central serous retinopathy: case-control analysis of a US national managed care population.中心性浆液性脉络膜视网膜病变发病风险因素:美国全国管理式医疗人群病例对照分析。
Br J Ophthalmol. 2019 Dec;103(12):1784-1788. doi: 10.1136/bjophthalmol-2018-313050. Epub 2019 Mar 14.
10
Subclinical hypercortisolism in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变中的亚临床皮质醇增多症
Retin Cases Brief Rep. 2014 Fall;8(4):310-3. doi: 10.1097/ICB.0000000000000036.